Optimization of dendritic cell maturation and gene transfer by recombinant adenovirus George MillerSvenja LahrsRonald P. DeMatteo Original Article 12 March 2003 Pages: 347 - 358
Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor Silvia FerrariBianca RovatiMarco Danova Original Article 27 March 2003 Pages: 359 - 366
A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells Pamela KruegerChristina NitzCohava Gelber Original Article 01 April 2003 Pages: 367 - 377
Interferon-α and interleukin-12 gene therapy of cancer: interferon-α induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing Jun-ichi EguchiKazumasa HiroishiKeiji Mitamura Original Article 18 March 2003 Pages: 378 - 386
Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine Michael G. E. O'RourkeMaree JohnsonChristopher W. Schmidt Original Article 08 April 2003 Pages: 387 - 395
High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress Scott N. ByrneGary M. Halliday Original Article 05 March 2003 Pages: 396 - 402
International conference: Progress in vaccination against cancer (PIVAC) 2002, Nottingham, UK Robert C. ReesR. Adrian RobinsIan Spendlove Symposium Series 09 April 2003 Pages: 403 - 407
